KEPIVANCE Safety Questions, KEPIVANCE Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about KEPIVANCE. Our extensive database of KEPIVANCE adverse events and KEPIVANCE warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about KEPIVANCE
KEPIVANCE Safety Reports
Total KEPIVANCE reports: 27.KEPIVANCE FDA safety alerts: No.
Reported hospitalizations: 19.
Take KEPIVANCE Side Effects Survey or Share Your KEPIVANCE Story. Read More Here.
Physician from HUNGARY reported KEPIVANCE problem on Jan 09, 2007. Female patient, weighting 121.3 lb, was diagnosed with mucosal inflammation and was treated with KEPIVANCE. After drug was administered, patient experienced the following problems/side effects: dysgeusia, erythema, face oedema, lip oedema, oral mucosal discolouration, oropharyngeal swelling, pain, paraesthesia oral. KEPIVANCE dosage: unknown. During the same period patient was treated with LANSOPRAZOLE, POTASSIUM CHLORIDE, FUROSEMIDE, SPIRONOLACTONE, ACYCLOVIR, FLUCONAZOLE, ALLOPURINOL, MEDROXYPROGESTERONE. Patient recovered.
KEPIVANCE problem was reported by a Physician from CANADA on Mar 05, 2007. Female patient, weighting 119.5 lb, was diagnosed with stomatitis and was treated with KEPIVANCE. After drug was administered, patient experienced the following problems/side effects: body temperature decreased, urticaria. KEPIVANCE dosage: unknown. During the same period patient was treated with AMPHOJEL, SYNTHROID, ACYCLOVIR, ZOFRAN, URSODIOL, PROTONIX. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported KEPIVANCE problem on Mar 07, 2007. Female patient, weighting 103.6 lb, was diagnosed with mucosal inflammation and was treated with KEPIVANCE. After drug was administered, patient experienced the following problems/side effects: anaemia, anorexia, diarrhoea, dysphagia, gait disturbance, gamma-glutamyltransferase increased, leukopenia, neutropenia. KEPIVANCE dosage: unknown. During the same period patient was treated with ALKERAN, LUTENYL, OGAST, LEXOMIL, ZOLPIDEM TARTRATE, BOANMYCIN. Patient was hospitalized and became disabled. Patient recovered.
KEPIVANCE problem was reported by a Health Professional from FRANCE on Mar 19, 2007. Female patient, 13 years of age, was diagnosed with mucosal inflammation and was treated with KEPIVANCE. After drug was administered, patient experienced the following problems/side effects: cardiac failure, hepatic failure. KEPIVANCE dosage: unknown. During the same period patient was treated with DOXORUBICIN. Patient recovered.
Physician from CANADA reported KEPIVANCE problem on Mar 20, 2007. Female patient, weighting 119.5 lb, was diagnosed with stomatitis and was treated with KEPIVANCE. After drug was administered, patient experienced the following problems/side effects: body temperature decreased, urticaria. KEPIVANCE dosage: unknown. During the same period patient was treated with AMPHOJEL, SYNTHROID, ACYCLOVIR, ZOFRAN, URSODIOL, PROTONIX, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.
KEPIVANCE problem was reported by a Physician from FRANCE on May 03, 2007. Female patient, 38 years of age, weighting 116.8 lb, was treated with KEPIVANCE. After drug was administered, patient experienced the following problems/side effects: acute pulmonary oedema, acute respiratory distress syndrome, pericardial effusion, pericarditis, pleural effusion. KEPIVANCE dosage: unknown. During the same period patient was treated with ENDOXAN, THYMOGLOBULIN, METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.
Physician from BELGIUM reported KEPIVANCE problem on May 29, 2007. Male patient, 46 years of age, weighting 200.6 lb, was treated with KEPIVANCE. After drug was administered, patient experienced the following problems/side effects: mucosal inflammation, swollen tongue. KEPIVANCE dosage: unknown. Patient recovered.
KEPIVANCE problem was reported by a Physician from BELGIUM on June 12, 2007. Male patient, 46 years of age, weighting 200.6 lb, was diagnosed with mucosal inflammation and was treated with KEPIVANCE. After drug was administered, patient experienced the following problems/side effects: mucosal haemorrhage, mucosal inflammation, swollen tongue. KEPIVANCE dosage: unknown. Patient recovered.
Physician from GERMANY reported KEPIVANCE problem on June 22, 2006. Male patient, weighting 211.6 lb, was diagnosed with mucosal inflammation and was treated with KEPIVANCE. After drug was administered, patient experienced the following problems/side effects: blister, dysaesthesia, dysgeusia, erythema, oedema peripheral, pain, tongue disorder. KEPIVANCE dosage: unknown. During the same period patient was treated with VINCRISTINE, IFOSFAMIDE, ETOPOSIDE, CORTISONE, RITUXIMAB, METHOTREXATE. Patient was hospitalized. Patient recovered.
KEPIVANCE problem was reported by a Pharmacist from CANADA on July 25, 2006. Male patient, weighting 180.8 lb, was diagnosed with stomatitis and was treated with KEPIVANCE. After drug was administered, patient experienced the following problems/side effects: blister, erythema, mucosal inflammation, neuropathy, neutrophil count increased, oedema peripheral, oral viral infection, petechiae, rash maculo-papular. KEPIVANCE dosage: unknown. During the same period patient was treated with NEUPOGEN, ETOPOSIDE, MELPHALAN. Patient was hospitalized. Patient recovered.
Physician from CANADA reported KEPIVANCE problem on July 25, 2006. Male patient, weighting 180.8 lb, was diagnosed with stomatitis and was treated with KEPIVANCE. After drug was administered, patient experienced the following problems/side effects: blister, erythema, mucosal inflammation, neuropathy, neutrophil count increased, oedema peripheral, oral viral infection, petechiae, rash maculo-papular. KEPIVANCE dosage: unknown. During the same period patient was treated with NEUPOGEN, ETOPOSIDE, MELPHALAN, TOBRAMYCIN, CEFAZOLIN, PIPERACILLIN. Patient was hospitalized. Patient recovered.
KEPIVANCE problem was reported by a Physician from FRANCE on Sept 15, 2006. Male patient, 40 years of age, was diagnosed with mucosal inflammation and was treated with KEPIVANCE. After drug was administered, patient experienced the following problems/side effects: periorbital oedema. KEPIVANCE dosage: unknown. During the same period patient was treated with ETOPOSIDE. Patient recovered.
Consumer or non-health professional from UNITED STATES reported KEPIVANCE problem on Oct 02, 2006. Male patient, 62 years of age, was diagnosed with stomatitis and was treated with KEPIVANCE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, dysgeusia, dyspnoea, macroglossia, mucosal inflammation, neutropenia, oedema peripheral, oral pain, osteonecrosis. KEPIVANCE dosage: unknown. During the same period patient was treated with LISINOPRIL, PANTOPRAZOLE, TAMSULOSIN, FENTANYL, OXYCONTIN, MELPHALAN. Patient recovered.
KEPIVANCE problem was reported by a Health Professional from FRANCE on Oct 16, 2006. Male patient, 61 years of age, was treated with KEPIVANCE. After drug was administered, patient experienced the following problems/side effects: erythema, eyelid oedema, toxic skin eruption. KEPIVANCE dosage: unknown. During the same period patient was treated with ATENOLOL, ALLOPURINOL, ALKERAN, NEXIUM, VFEND. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported KEPIVANCE problem on Sept 15, 2006. Male patient, 39 years of age, weighting 242.5 lb, was diagnosed with mucosal inflammation and was treated with KEPIVANCE. After drug was administered, patient experienced the following problems/side effects: periorbital oedema, rash. KEPIVANCE dosage: unknown. During the same period patient was treated with MITOXANTRONE, ARACYTINE. Patient recovered.
KEPIVANCE problem was reported by a Physician from CANADA on Sept 29, 2006. Male patient, weighting 229.3 lb, was diagnosed with stomatitis and was treated with KEPIVANCE. After drug was administered, patient experienced the following problems/side effects: clostridial infection, colectomy, gastrointestinal necrosis, neutropenic colitis. KEPIVANCE dosage: unknown. During the same period patient was treated with ETOPOSIDE, MELPHALAN, ONDANSETRON, DEXAMETHASONE, DOMPERIDONE. Patient was hospitalized. Patient recovered.
Health Professional from FRANCE reported KEPIVANCE problem on Oct 16, 2006. Male patient, 61 years of age, was treated with KEPIVANCE. After drug was administered, patient experienced the following problems/side effects: erythema, eyelid oedema, toxic skin eruption. KEPIVANCE dosage: unknown. During the same period patient was treated with ATENOLOL, ALLOPURINOL, ALKERAN, NEXIUM, VFEND. Patient was hospitalized. Patient recovered.
KEPIVANCE problem was reported by a Physician from CANADA on Sept 29, 2006. Male patient, weighting 229.3 lb, was diagnosed with stomatitis and was treated with KEPIVANCE. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, clostridial infection, delayed engraftment, febrile neutropenia, gastrointestinal necrosis, hypotension, impaired healing, international normalised ratio increased, jaundice. KEPIVANCE dosage: unknown. During the same period patient was treated with ETOPOSIDE, MELPHALAN, ONDANSETRON, DEXAMETHASONE, DOMPERIDONE. Patient was hospitalized. Patient recovered.
Physician from HUNGARY reported KEPIVANCE problem on Oct 11, 2006. Female patient, weighting 121.3 lb, was diagnosed with mucosal inflammation and was treated with KEPIVANCE. After drug was administered, patient experienced the following problems/side effects: dysgeusia, erythema, face oedema, oedema genital, oral mucosal discolouration, oropharyngeal swelling, pain, paraesthesia oral. KEPIVANCE dosage: unknown. During the same period patient was treated with LANSOPRAZOLE, POTASSIUM CHLORIDE, FUROSEMIDE INTENSOL, SPIRONOLACTONE, ACYCLOVIR, FLUCONAZOLE, ALLOPURINOL, MEDROXYPROGESTERONE. Patient recovered.
KEPIVANCE problem was reported by a Physician from GREECE on July 04, 2007. Female patient, weighting 112.4 lb, was diagnosed with mucosal inflammation and was treated with KEPIVANCE. After drug was administered, patient experienced the following problems/side effects: guillain-barre syndrome. KEPIVANCE dosage: unknown. During the same period patient was treated with GRANULOKINE, HEPARIN, ABELCET, CIPROXIN, ZOVIRAX, ZANTAC, ANTIHISTAMINES. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported KEPIVANCE problem on July 06, 2007. Female patient, weighting 103.6 lb, was diagnosed with mucosal inflammation and was treated with KEPIVANCE. After drug was administered, patient experienced the following problems/side effects: anaemia, anorexia, diarrhoea, dysphagia, gait disturbance, gamma-glutamyltransferase increased, hypokalaemia, leukopenia. KEPIVANCE dosage: unknown. During the same period patient was treated with MELPHALAN, BUSULFAN, ALKERAN, LUTENYL, OGAST, LEXOMIL, ZOLPIDEM TARTRATE, BOANMYCIN. Patient was hospitalized and became disabled. Patient recovered.
KEPIVANCE problem was reported by a Physician from BELGIUM on July 11, 2007. Female patient, weighting 132.3 lb, was diagnosed with mucosal inflammation and was treated with KEPIVANCE. After drug was administered, patient experienced the following problems/side effects: anorexia, diarrhoea, febrile neutropenia, gastritis, hypoalbuminaemia, lung infiltration, mouth haemorrhage, oesophagitis, sepsis. KEPIVANCE dosage: unknown. During the same period patient was treated with LORAZEPAM, ZESTRIL, MELPHALAN, ZOFRAN, CETIRIZINE. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported KEPIVANCE problem on Aug 02, 2007. Female patient, 38 years of age, weighting 116.8 lb, was treated with KEPIVANCE. After drug was administered, patient experienced the following problems/side effects: acute pulmonary oedema, acute respiratory distress syndrome, pericardial effusion, pericarditis, pleural effusion. KEPIVANCE dosage: unknown. During the same period patient was treated with ENDOXAN, THYMOGLOBULIN, METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.
KEPIVANCE problem was reported by a Physician from BELGIUM on Aug 07, 2007. Female patient, weighting 132.3 lb, was diagnosed with mucosal inflammation and was treated with KEPIVANCE. After drug was administered, patient experienced the following problems/side effects: anorexia, diarrhoea, febrile neutropenia, gastritis, hypoalbuminaemia, lung infiltration, mouth haemorrhage, oesophagitis, sepsis. KEPIVANCE dosage: unknown. During the same period patient was treated with LORAZEPAM, ZESTRIL, MELPHALAN, ZOFRAN, CETIRIZINE. Patient was hospitalized. Patient recovered.
Pharmacist from AUSTRALIA reported KEPIVANCE problem on Aug 23, 2007. Male patient, weighting 183.0 lb, was diagnosed with mucosal inflammation and was treated with KEPIVANCE. After drug was administered, patient experienced the following problems/side effects: chills, dyspnoea, hypoaesthesia, pyrexia, sepsis. KEPIVANCE dosage: unknown. Patient was hospitalized. Patient recovered.
KEPIVANCE problem was reported by a Physician from BELGIUM on Sept 18, 2007. Female patient, weighting 132.3 lb, was diagnosed with mucosal inflammation and was treated with KEPIVANCE. After drug was administered, patient experienced the following problems/side effects: anorexia, diarrhoea, febrile neutropenia, gastritis, hypoalbuminaemia, lung infiltration, mouth haemorrhage, oesophagitis, sepsis. KEPIVANCE dosage: unknown. During the same period patient was treated with TEMESTA, ZESTRIL, MELPHALAN, ZOFRAN, CETIRIZINE. Patient was hospitalized. Patient recovered.
Pharmacist from AUSTRALIA reported KEPIVANCE problem on Sept 19, 2007. Male patient, weighting 183.0 lb, was diagnosed with mucosal inflammation and was treated with KEPIVANCE. After drug was administered, patient experienced the following problems/side effects: chills, dyspnoea, hypoaesthesia, pyrexia, sepsis. KEPIVANCE dosage: unknown. During the same period patient was treated with CARMUSTINE, ETOPOSIDE, CYTARABINE, MELPHALAN, METHOTREXATE. Patient was hospitalized. Patient recovered.